Read more
Sassano: Why future EU medical cannabis branding is essential
Michael Sassano is a CEO and Chairman of the Board for SOMAÍ Pharmaceuticals, a leading EU-GMP European pharmaceutical and biotech...
Read more
SOMAÍ Pharmaceuticals Expands Its Most Comprehensive Medicinal Cannabis Portfolio With Launch of New Mint Oral Solutions Line
SOMAÍ Pharmaceuticals (“SOMAÍ”), a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, is proud to announce...
Read more
Financial Times: European cannabis companies start IPO planning as US considers looser rules
A number of European cannabis start-ups are planning to go public in New York to take advantage of a US...
Read more
Put Some Mint Terpenes In It
What is the first thing you do when you open a new bag of cannabis flower? You smell it! Cannabis...
Read more
Cannabiz: SOMAÍ Pharmaceuticals ‘keeps promise’ to deliver expanded product range
SOMAÍ Pharmaceuticals is rolling out a suite of new products in Australia as it aims to back up its pledge...
Read more
Germany Leads The Global Medical Cannabis Explosion
The entire cannabis community is abuzz with German legalization. Not only is this a massive windfall for cannabis producers around the...
Read more
A Comparison Of Legal And Illicit EU Cannabis Markets
Co-Authored by Michael Sassano and Callum Kellas The cannabis illicit market existed in all countries long before the legal markets...
Read more
European Cannabis Q1 2024 Quarterly Update
2024 ushered in one of the most reformatory changes that the global medical cannabis community has ever witnessed. The EU...
Read more
Breaking Down Barriers to Medical Cannabis in the UK: Business of Cannabis
UK medical cannabis patients are facing multiple challenges that are preventing the adoption of the legal market. From stigmatisation and...